0001570562-24-000005.txt : 20240202 0001570562-24-000005.hdr.sgml : 20240202 20240202165732 ACCESSION NUMBER: 0001570562-24-000005 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240130 FILED AS OF DATE: 20240202 DATE AS OF CHANGE: 20240202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Parschauer Karah Herdman CENTRAL INDEX KEY: 0001677455 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38381 FILM NUMBER: 24592444 MAIL ADDRESS: STREET 1: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evolus, Inc. CENTRAL INDEX KEY: 0001570562 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 461385614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 520 NEWPORT CENTER DRIVE STREET 2: SUITE 1200 CITY: NEWPORT BEACH STATE: CA ZIP: 92660 BUSINESS PHONE: (949) 284-4555 MAIL ADDRESS: STREET 1: 520 NEWPORT CENTER DRIVE STREET 2: SUITE 1200 CITY: NEWPORT BEACH STATE: CA ZIP: 92660 4 1 wk-form4_1706911039.xml FORM 4 X0508 4 2024-01-30 0 0001570562 Evolus, Inc. EOLS 0001677455 Parschauer Karah Herdman 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 1 0 0 0 1 Common Stock 2024-01-30 4 S 0 11931 13.1366 D 31243 D The shares were sold in multiple trades at prices ranging from $13.025 to $13.34. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Shares sold pursuant to a 10b5-1 plan adopted in August 2023. /s/ Jeffrey J. Plumer, as attorney-in-fact for Karah Parschauer 2024-02-02